Recent Posts
- Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations
- Update on Inflammatory Biomarkers for Defining Asthma Phenotype
- Precision medicine targeting groups of intervention in difficult-to-treat asthma
- Run-in periods and treatment outcomes in asthma trials: a narrative review
- Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor Antagonists Versus Inhaled Corticosteroids